NCT01853605View on ClinicalTrials.gov

NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study

NATerminatedINTERVENTIONAL
Enrollment

3,811

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Breast AugmentationBreast ReconstructionBreast Implant Revision
Interventions
DEVICE

Anatomically shaped silicone gel-filled breast implants

Surgical implant

Trial Locations (1)

Unknown

Eugene

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01853605 - NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study | Biotech Hunter | Biotech Hunter